|
AU2020103435A4
|
|
Method for preparing (s)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid and derivatives thereof
|
|
WO2021047565A1
|
|
Method for preparing (r)-praziquantel and chiral intermediate thereof, and composition
|
|
WO2021047566A1
|
|
Preparation method for (r)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, derivative thereof and levo-praziquantel
|
|
US2017121330A1
|
|
Process for the synthesis of (R)-praziquantel
|
|
WO2016138793A1
|
|
Disposable intranasal brain-targeting drug delivery apparatus
|
|
WO2016138794A1
|
|
Disposable intranasal brain-targeting drug delivery apparatus
|
|
WO2016138796A1
|
|
Disposable intranasal brain-targeting drug delivery apparatus
|
|
WO2016138795A1
|
|
Disposable intranasal brain-targeting drug delivery apparatus
|
|
AU2015381503A1
|
|
Lipid nanoparticles and uses thereof
|
|
AU2014336747A1
|
|
Crystal form of (r)-praziquantel and preparation method and application thereof
|
